skip to content

Department of Chemical Engineering and Biotechnology

 

Buckingham Palace The Department of Chemical Engineering is delighted to congratulate The Institute of Biotechnology which has been recognised for its unique combination of innovative multidisciplinary research, education and entrepreneurialism with The Queen's Anniversary Prize for Higher and Further Education.

Professor Lynn Gladden (Head of the Department of Chemical Engineering) joined Professor Alison Richard (Vice Chancellor of the University of Cambridge), Professor Ian White (Chairman of the School of Technology), Professor Chris Lowe (Director of the Institute of Biotechnology) and a group of key staff members and students from the Institute's PhD and Masters in Bioscience Enterprise programmes as they attended Buckingham Palace on 14th February 2008 to receive this prestigious prize from Her Majesty Queen Elizabeth and His Royal Highness Prince Philip. The event was also marked by a dinner at London's Guildhall, attended by 400 guests from academia and business.

Buckingham PalaceThe Department of Chemical Engineering looks forward to sharing skills with, and learning from, the Institute of Biotechnology as the planned merger between the two organisations progresses. As Professor Gladden says 'This is a very exciting period in the development of both our organisations. Many people have worked extremely hard to create two vibrant centres of teaching and research. We are thrilled that the work of the Institute of Biotechnology has been publicly recognised at the highest level in this way and look forward to working ever more closely together.'

 

Latest news

New heart valve could transform open heart surgery for millions of patients globally

29 June 2020

The new polymeric heart valve, developed by scientists at the universities of Bristol and Cambridge, prevents the need for life-long blood thinning medication.

Shaping the world

23 June 2020

CEB researchers Beth Tennyson and Jana Weber named in WES Top 50 engineers awards

Continuous synthesis of iron nanoparticles could open up their use as anti-cancer treatment

9 June 2020

PhD student, Julien Mahin, from our Process Integration group, has developed a new method to produce single-sized magnetic nanoparticles with promising medicinal applications.